Table S3 from Aberrant Hippo-YAP/TEAD Signaling Drives Malignant Transcriptional Reprogramming in External Auditory Canal Squamous Cell Carcinoma

Kuniaki Sato; Noritaka Komune; Mayumi Ono; Shinsaku Itoyama; Takahiro Hongo; Takafumi Nakano; Kensuke Koike; Kenichi Taguchi; Koshi Mimori; Jorge Silvio Gutkind; Muneyuki Masuda; Takashi Nakagawa

doi:10.1158/2767-9764.31268605

Table S3 from Aberrant Hippo-YAP/TEAD Signaling Drives Malignant Transcriptional Reprogramming in External Auditory Canal Squamous Cell Carcinoma

2026 Open access

Read full text

Authors: Kuniaki Sato, Noritaka Komune, Mayumi Ono, Shinsaku Itoyama, Takahiro Hongo, Takafumi Nakano, Kensuke Koike, Kenichi Taguchi, Koshi Mimori, Jorge Silvio Gutkind, Muneyuki Masuda, Takashi Nakagawa

DOI: 10.1158/2767-9764.31268605

Cited by: 0

Abstract

Multivariate analyses of YAP and PITX2 expression with clinicopathological factors for overall survival in the EACSCC patients in Figure 5.

Fields of Study & Subjects

Hippo pathway signaling and YAP/TAZ Ear and Head Tumors Cancer-related molecular mechanisms research

Publication details

Publication date: 5 February 2026